gip glp 1 agonist tirzepatide Frontiers glp 1 gip triple agonist
Description
3 Evidence suggests that the number of prescriptions for these drugs has increased significantly
JAMA Netw Open 2022;5:e2231982.ArticlePubMedPMC 9
J.AhrnB.et al (2004)
Multiple studies demonstrate that proliferation due to incretin mimetics can lead to duct occlusion, promoting the premature release of pancreatic enzymes, thereby triggering acinar cell death 18,26
